semaglutide en france becomes first EU country to reimburse anti-obesity drugs, minister says France will cover the costs

It works by mimicking the bodys natural GLP-1 hormone to help regulate appetite, increase feelings of fullness, and reduce food intake

The worldwide semaglutide market size is predicted to be worth USD 173.59 million by 2033 from USD 115.72 million in 2025, growing at a CAGR of 5.2% from 2025 to 2033

found that base modification could considerably reduce the hepatotoxicity of gapmer ASO, 245 providing insights for developing new gapmer ASOs

We need several large-scale trials to assess safety, particularly in young and middle-aged women, [who] constitute the majority of the population with migraine. The Managing migraine nowadays has been very advanced, and it depends on the cause and frequency of the migraine, said Mikhael